dr R K Alwadhi
Consultant Pediatrician
Centre for Child Health, BLK Super Speciality Hospital
About Author

IAP Advisory Committee on Vaccines & Immunization(ACVIP) endorses the use of Rabies Human Monoclonal Antibody(RHMAB) as an alternative to Rabies Immuno Globulin (RIG) – human or equine – along with rabies vaccines in all category-III bites.

RHMAB is licensed in India and is available as Rabisheild by Serum Institute of India.

Preparation available as 2.5 ml vial with 100U RHMAB per vial.

The recommended dose is 3.33 IU/kg body weight,  same for children and adults. The dose should preferably be given at the time of the first vaccine dose, however, this may also be administered up to the 7th day after the first dose of vaccine is given. 



Posted On: 14/03/2019

Did you find this post helpful?
Yes (10)
No (59)
10 People found this post helpful.

Read more related information, Click Here

If you have a question on some other topic, Click Here

top hospitals in india
To visit our website please click here
Address:
BLK Super Speciality Hospital
Pusa Road, New Delhi-110005
Disclaimer: Although every effort is made to give correct knowledge but legality of every answer can not be guaranteed. All answers are based on professional knowledge of Specialists.